SLC5A2 and diabetic kidney disease: The co-cited literature is synthesized into 16 clusters (numbered from 0 to 15 by size), among which the 9 main clusters with active co-citation relationships are as follows (Figure 6B), SGLT2 inhibitor (#0), mitochondrial dysfunction (#1), diabetic function disease (#2), diabetic kidney disease (#3), anti-aging molecule sirt1 (#4), non-coding RNA (#5), mitochondrial dysfunction (#12), pathophysiology (#14), and the p70s6k1 signaling pathway (#15).